@support my main account, @GaladonGaming, has been locked out for almost a month, because the 2FA text isn't coming through to my phone.
6 emails to support have been replied with only automated responses.
PLEASE HELP!
@FingerMotionInc (@Nasdaq $FNGR) is making waves in the tech world as an evolving company with a strong foothold in mobile payment and recharge platform solutions in China.
Key Highlights:
Exclusive Access: One of the few companies in China with access to wholesale rechargeable minutes from the largest mobile providers.
Rapid Growth: Our user base is expanding, and we're developing innovative, value-added technologies for our users.
Vision for the Future: Aiming to build a highly engaged ecosystem, strategically positioning ourselves to onboard even larger customer bases.
With a goal to serve over 1 billion users in China and expand to other regional markets, FingerMotion is poised for explosive growth!
Invest in the Future of Mobile Technology. https://t.co/smGim4fJ6f
#FingerMotion #TechInnovation #MobilePayment #InvestorOpportunity #Growth #ChinaMarket #EvolvingTech
@Kenneth83risom Oh trust me, I've done my DD- I'm a FULL believer in the efficacy of $NWBO's #DCVax - not sure I see $100/share but it is certainly worth more than current levels, in my opinion!
I predict that $NWBO market cap passes $NVCR market cap in 2023.
I predict that $NWBO share price passes $NVCR share price in 2024.
Not investment advice.
We are now WITHIN that 30-45 day window! $NWBO
"The Company anticipates submitting the MAA in approximately the next 30-45 days. The Company plans to request that the MHRA review the MAA under the 150-business day process..."
https://t.co/nNxf1UW86W
Excitement building for $NWBO and #DCVax - MAA submission likely within the next 2 weeks, Dr. Linda Liau on the SAB - LOTS of short term positive catalysts for this one!
Don't take my word for it:
https://t.co/Sk1LV2JhTT
My price targets for $NWBO:
PR of MHRA submission/acceptance - $1.21
Announcement of MHRA approval - $3.87
FDA approval or buyout - $22.00
NOT investment advice.
Tonight we heard a recording of $NWBO Les Goldman on the Big Biz Show. I recommend readers listen to him (link below). From minutes 25-35 approximately. He will be on the show next week too. The discussion was about how prominent the journal JAMA Oncology was, that four applications are being submitted to regulators who are excited about it, that 800 patients have been treated with DCVax to date (including in Israel), that naked short selling is really the key of the lawsuit if not mentioned explicitly, and that there are many vested interests attacking $NWBO because DCVax costs much less, is curative, and has zero side effects. What he said is great and current investors are largely aware of it; but more importantly, the audience is millions of potential investors who are beginning to understand what this isβ¦